APM
Aptorum Group Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$8.26
−14.84%Latest reported
- Last report date
- Oct 3, 2025
- EPS actual
- -$0.06
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +65.3%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 3, 2025 | — | -$0.06 | — | — |
| Dec 20, 2024 | — | -$0.50 | — | — |
| Apr 30, 2024 | -$2.70 | $0.51 | Beat 119.04% | — |
| Dec 22, 2023 | -$2.60 | -$1.43 | Beat 45.19% | $431.4K |
| Apr 28, 2023 | -$2.60 | -$2.22 | Beat 14.76% | $768.4K |
| Sep 30, 2022 | -$3.00 | -$0.53 | Beat 82.39% | $527.5K |
| Apr 29, 2022 | -$3.30 | -$2.52 | Beat 23.76% | $904.0K |
| Dec 3, 2021 | -$3.00 | -$4.69 | Miss -56.37% | $637.8K |
| Apr 19, 2021 | -$3.10 | $3.90 | Beat 225.81% | $584.2K |
| Sep 1, 2020 | -$2.50 | -$2.07 | Beat 17.16% | $327.3K |
| Apr 29, 2020 | — | -$3.31 | — | $295.4K |
| Sep 9, 2019 | — | -$3.14 | — | $239.8K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026